Weekly Digest – August 2025 Weekly Digest – August 2025 11 August 2025: Junshi Biosciences Announces the Acceptance of the sNDA for Toripalimab as the 1st-line Treatment of HER2-expressing Urothelial Carcinoma Junshi Bioscience’s supplemental new drug application (sNDA) for toripalimab […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id